Chronic low-grade inflammation, characterized by persistent elevation of pro-inflammatory cytokines (e.g., IL-6, TNF-α), and metabolic syndrome components, including insulin resistance, hypertension, and dyslipidemia, have been identified as shared risk factors for both conditions. This evidence concerns the gene IL6 and metabolic syndrome.